139 Cervical cancer screening among marginalized women Supplementary Table: Prevalence rates of HR-HPV+ & abnormal smears per age cohort of women screened by the Dutch CSP. Regional data from 201815 Screened HPV-HR+ HR-HPV+ & abnormal smear Count (n) Count (n) Prevalence Count (n) Prevalence Age cohort 20-25* - 25-30* - 30-35 12247 2448 0.20 931 0.076 35-40 12745 1587 0.12 578 0.045 40-45 14114 1280 0.09 449 0.032 45-50 15152 1265 0.08 434 0.029 50-55 16920 1181 0.07 367 0.022 55-60 16764 1005 0.06 230 0.014 Total 87942 8766 0.10 2989 0.034 *Women in these age cohorts are not screened by the Dutch CSP. HR-HPV+ = High Risk Human Papillomavirus positive, CSP = Cancer Screening Programme 5
RkJQdWJsaXNoZXIy MTk4NDMw